Johan Lennerstrand

1.9k total citations
53 papers, 1.3k citations indexed

About

Johan Lennerstrand is a scholar working on Infectious Diseases, Virology and Molecular Biology. According to data from OpenAlex, Johan Lennerstrand has authored 53 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Infectious Diseases, 20 papers in Virology and 17 papers in Molecular Biology. Recurrent topics in Johan Lennerstrand's work include HIV/AIDS drug development and treatment (24 papers), HIV Research and Treatment (20 papers) and Hepatitis C virus research (14 papers). Johan Lennerstrand is often cited by papers focused on HIV/AIDS drug development and treatment (24 papers), HIV Research and Treatment (20 papers) and Hepatitis C virus research (14 papers). Johan Lennerstrand collaborates with scholars based in Sweden, Germany and United Kingdom. Johan Lennerstrand's co-authors include Brendan Larder, Navaneethan Palanisamy, D.K. Stammers, Jonas Bergh, Åke Lundkvist, Dario Akaberi, Josef D. Järhult, Tara L. Kieffer, Edward Tam and Neil Parkin and has published in prestigious journals such as PLoS ONE, Hepatology and Analytical Biochemistry.

In The Last Decade

Johan Lennerstrand

52 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Johan Lennerstrand Sweden 15 617 427 359 313 305 53 1.3k
Fayez M. Hamzeh United States 22 388 0.6× 986 2.3× 633 1.8× 191 0.6× 184 0.6× 42 1.7k
Samir Ali Denmark 14 315 0.5× 384 0.9× 488 1.4× 222 0.7× 47 0.2× 37 915
Shubham Shrivastava United States 23 509 0.8× 727 1.7× 500 1.4× 767 2.5× 78 0.3× 46 2.1k
Takahiro Masaki Japan 22 146 0.2× 775 1.8× 943 2.6× 641 2.0× 115 0.4× 59 1.7k
William E. Hornbuckle United States 20 287 0.5× 1.1k 2.5× 750 2.1× 207 0.7× 89 0.3× 35 1.4k
A. Mühlbacher Austria 14 321 0.5× 223 0.5× 126 0.4× 143 0.5× 203 0.7× 26 826
Christophe Ramière France 18 305 0.5× 478 1.1× 518 1.4× 200 0.6× 71 0.2× 33 1.0k
Alexander S. Kekulé Germany 13 165 0.3× 767 1.8× 427 1.2× 334 1.1× 37 0.1× 27 1.1k
Laura Fantuzzi Italy 22 235 0.4× 298 0.7× 138 0.4× 227 0.7× 563 1.8× 39 1.5k

Countries citing papers authored by Johan Lennerstrand

Since Specialization
Citations

This map shows the geographic impact of Johan Lennerstrand's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Johan Lennerstrand with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Johan Lennerstrand more than expected).

Fields of papers citing papers by Johan Lennerstrand

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Johan Lennerstrand. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Johan Lennerstrand. The network helps show where Johan Lennerstrand may publish in the future.

Co-authorship network of co-authors of Johan Lennerstrand

This figure shows the co-authorship network connecting the top 25 collaborators of Johan Lennerstrand. A scholar is included among the top collaborators of Johan Lennerstrand based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Johan Lennerstrand. Johan Lennerstrand is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Akaberi, Dario, Janina Krambrich, J.M. Berger, et al.. (2024). Identification of novel and potent inhibitors of SARS-CoV-2 main protease from DNA-encoded chemical libraries. Antimicrobial Agents and Chemotherapy. 68(10). e0090924–e0090924. 4 indexed citations
3.
Palanisamy, Navaneethan, Paula Mölling, Johan Lindh, et al.. (2023). Prevalence of SARS-CoV-2 Omicron Sublineages and Spike Protein Mutations Conferring Resistance against Monoclonal Antibodies in a Swedish Cohort during 2022–2023. Microorganisms. 11(10). 2417–2417. 3 indexed citations
4.
Akaberi, Dario, Praveen K. Chinthakindi, T. Nyman, et al.. (2021). Targeting the NS2B-NS3 protease of tick-borne encephalitis virus with pan-flaviviral protease inhibitors. Antiviral Research. 190. 105074–105074. 14 indexed citations
5.
Akaberi, Dario, Janina Krambrich, Jiaxin Ling, et al.. (2020). Mitigation of the replication of SARS-CoV-2 by nitric oxide in vitro. Redox Biology. 37. 101734–101734. 133 indexed citations
6.
Kanestrøm, Anita, Karoline Bragstad, Susanne Dudman, et al.. (2016). Usage of Antivirals and the Occurrence of Antiviral Resistance in Norway 2015. BIBSYS Brage (BIBSYS (Norway)). 2 indexed citations
7.
Palanisamy, Navaneethan, et al.. (2016). SYBR Green II Dye-Based Real-Time Assay for Measuring Inhibitor Activity Against HIV-1 Reverse Transcriptase. Molecular Biotechnology. 58(10). 619–625. 7 indexed citations
8.
Bergqvist, Anders, et al.. (2015). Analysis of hepatitis C NS5A resistance associated polymorphisms using ultra deep single molecule real time (SMRT) sequencing. Antiviral Research. 126. 81–89. 15 indexed citations
9.
10.
Palanisamy, Navaneethan, et al.. (2013). Implications of baseline polymorphisms for potential resistance to NS3 protease inhibitors in Hepatitis C virus genotypes 1a, 2b and 3a. Antiviral Research. 99(1). 12–17. 54 indexed citations
11.
Lennerstrand, Johan, et al.. (2011). Detection of Resistance Mutations to Antivirals Oseltamivir and Zanamivir in Avian Influenza A Viruses Isolated from Wild Birds. PLoS ONE. 6(1). e16028–e16028. 57 indexed citations
12.
Lennerstrand, Johan, Kåre Bondeson, Anders Bergqvist, Jonas Blomberg, & Bo Öberg. (2010). [New antiviral agents against hepatitis C in clinical trials. Hope for a cure--but resistance problems must be overcomed].. PubMed. 106(48). 3254–6, 3258, 3260. 1 indexed citations
13.
Schinazi, Raymond F., Steven J. Coats, Leda Bassit, et al.. (2008). Approaches for the Development of Antiviral Compounds: The Case of Hepatitis C Virus. Handbook of experimental pharmacology. 25–51. 9 indexed citations
14.
Lennerstrand, Johan, et al.. (2002). Application of a colorimetric chain‐termination assay for characterization of reverse transcriptase from 3′‐azido‐2′,3′‐deoxythymidine‐resistant HIV isolates. Biotechnology and Applied Biochemistry. 35(3). 155–164. 1 indexed citations
15.
Norberg, Torbjörn, Johan Lennerstrand, Mats Inganäs, & Jonas Bergh. (1998). Comparison between p53 protein measurements using the luminometric immunoassay and immunohistochemistry with detection of p53 gene mutations using cDNA sequencing in human breast tumors. International Journal of Cancer. 79(4). 376–383. 2 indexed citations
16.
Norberg, Torbjörn, Johan Lennerstrand, Mats Inganäs, & Jonas Bergh. (1998). Comparison between p53 protein measurements using the luminometric immunoassay and immunohistochemistry with detection ofp53 gene mutations using cDNA sequencing in human breast tumors. International Journal of Cancer. 79(4). 376–383. 49 indexed citations
17.
Lennerstrand, Johan, et al.. (1996). A Method for Combined Immunoaffinity Purification and Assay of HIV-1 Reverse Transcriptase Activity Useful for Crude Samples. Analytical Biochemistry. 235(2). 141–152. 9 indexed citations
18.
Borg, Åke, Johan Lennerstrand, Mårten Fernö, et al.. (1995). Prognostic significance of p53 overexpression in primary breast cancer; a novel luminometric immunoassay applicable on steroid receptor cytosols. British Journal of Cancer. 71(5). 1013–1017. 54 indexed citations
19.
Karlsson, Anders, et al.. (1992). HIV‐1 reverse transcriptase inhibiting antibody titer in serum: Relation to disease progression and to core‐antibody levels. Journal of Medical Virology. 36(4). 283–291. 6 indexed citations
20.
Gronowitz, J. Simon, et al.. (1991). Carrier bound templates for single tube reverse transcriptase assays and for combined purification and activity analyses, with special reference to HIV. Biotechnology and Applied Biochemistry. 13(1). 127–142. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Fayez M. Hamzeh Breakdown of academic impact, for papers by Samir Ali Breakdown of academic impact, for papers by Shubham Shrivastava Breakdown of academic impact, for papers by Takahiro Masaki Breakdown of academic impact, for papers by William E. Hornbuckle Breakdown of academic impact, for papers by A. Mühlbacher Breakdown of academic impact, for papers by Christophe Ramière Breakdown of academic impact, for papers by Alexander S. Kekulé Breakdown of academic impact, for papers by Laura Fantuzzi
Rankless by CCL
2026